A detailed history of Center For Financial Planning, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Center For Financial Planning, Inc. holds 776 shares of VTRS stock, worth $10,088. This represents 0.0% of its overall portfolio holdings.

Number of Shares
776
Previous 814 4.67%
Holding current value
$10,088
Previous $8,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$10.32 - $12.13 $392 - $460
-38 Reduced 4.67%
776 $9,000
Q2 2024

Jul 18, 2024

SELL
$10.05 - $12.02 $1,125 - $1,346
-112 Reduced 12.1%
814 $8,000
Q1 2024

Apr 25, 2024

BUY
$11.27 - $13.53 $326 - $392
29 Added 3.23%
926 $11,000
Q3 2023

Oct 24, 2023

SELL
$9.59 - $11.35 $230 - $272
-24 Reduced 2.61%
897 $8,000
Q2 2023

Aug 09, 2023

SELL
$9.02 - $10.29 $1,776 - $2,027
-197 Reduced 17.62%
921 $9,000
Q1 2023

May 02, 2023

SELL
$9.2 - $12.26 $368 - $490
-40 Reduced 3.45%
1,118 $10,000
Q4 2022

Jan 27, 2023

SELL
$8.72 - $11.56 $2,336 - $3,098
-268 Reduced 18.79%
1,158 $0
Q3 2022

Oct 14, 2022

BUY
$8.48 - $11.13 $8 - $11
1 Added 0.07%
1,426 $12,000
Q2 2022

Aug 12, 2022

SELL
$9.95 - $12.27 $3,064 - $3,779
-308 Reduced 17.77%
1,425 $15,000
Q1 2022

May 03, 2022

BUY
$9.81 - $15.4 $3,482 - $5,467
355 Added 25.76%
1,733 $19,000
Q4 2021

Feb 08, 2022

BUY
$12.09 - $14.68 $616 - $748
51 Added 3.84%
1,378 $19,000
Q3 2021

Oct 27, 2021

BUY
$13.25 - $15.13 $331 - $378
25 Added 1.92%
1,327 $18,000
Q2 2021

Jul 29, 2021

SELL
$12.97 - $16.15 $6,783 - $8,446
-523 Reduced 28.66%
1,302 $19,000
Q1 2021

May 10, 2021

SELL
$13.59 - $18.54 $2,106 - $2,873
-155 Reduced 7.83%
1,825 $25,000
Q4 2020

Feb 09, 2021

BUY
$14.3 - $18.74 $28,314 - $37,105
1,980 New
1,980 $37,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Center For Financial Planning, Inc. Portfolio

Follow Center For Financial Planning, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center For Financial Planning, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Center For Financial Planning, Inc. with notifications on news.